HK1111889A1 - Composition for prophylaxis or treatment of urinary system infection - Google Patents

Composition for prophylaxis or treatment of urinary system infection

Info

Publication number
HK1111889A1
HK1111889A1 HK08106526.2A HK08106526A HK1111889A1 HK 1111889 A1 HK1111889 A1 HK 1111889A1 HK 08106526 A HK08106526 A HK 08106526A HK 1111889 A1 HK1111889 A1 HK 1111889A1
Authority
HK
Hong Kong
Prior art keywords
prophylaxis
treatment
composition
urinary system
system infection
Prior art date
Application number
HK08106526.2A
Other languages
English (en)
Inventor
Chih-Hsuing Lin
Original Assignee
Chih-Hsuing Lin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chih-Hsuing Lin filed Critical Chih-Hsuing Lin
Publication of HK1111889A1 publication Critical patent/HK1111889A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK08106526.2A 2006-06-08 2008-06-12 Composition for prophylaxis or treatment of urinary system infection HK1111889A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/422,924 US8153166B2 (en) 2006-06-08 2006-06-08 Composition for prophylaxis or treatment of urinary system infection and method thereof

Publications (1)

Publication Number Publication Date
HK1111889A1 true HK1111889A1 (en) 2008-08-22

Family

ID=38462228

Family Applications (2)

Application Number Title Priority Date Filing Date
HK08106526.2A HK1111889A1 (en) 2006-06-08 2008-06-12 Composition for prophylaxis or treatment of urinary system infection
HK10108658.4A HK1142523A1 (en) 2006-06-08 2010-09-13 Composition for prophylaxis or treatment of urinary system infection

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK10108658.4A HK1142523A1 (en) 2006-06-08 2010-09-13 Composition for prophylaxis or treatment of urinary system infection

Country Status (7)

Country Link
US (2) US8153166B2 (zh)
EP (1) EP1880719A3 (zh)
JP (1) JP4786598B2 (zh)
CN (2) CN101670004B (zh)
AU (1) AU2007202584B2 (zh)
CA (1) CA2590995C (zh)
HK (2) HK1111889A1 (zh)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8153166B2 (en) 2006-06-08 2012-04-10 Chih-Hsiung Lin Composition for prophylaxis or treatment of urinary system infection and method thereof
MX2007006334A (es) * 2007-05-28 2009-02-18 World Trade Imp Export Wtie Ag Composicion farmaceutica que comprende la combinacion de un agente antimicrobiano y un agente antioxidante para el tratamiento de infecciones urinarias.
CN101868472B (zh) 2007-11-21 2013-05-29 尔察祯有限公司 抗菌性氨基糖苷类似物
CN102481306A (zh) * 2009-05-14 2012-05-30 尔察祯有限公司 使用抗菌氨基糖苷化合物治疗尿路感染
WO2010132768A1 (en) 2009-05-15 2010-11-18 Achaogen, Inc. Antibacterial derivatives of sisomicin
WO2010132759A1 (en) 2009-05-15 2010-11-18 Achaogen, Inc. Antibacterial derivatives of dibekacin
WO2010132765A2 (en) 2009-05-15 2010-11-18 Achaogen, Inc. Antibacterial aminoglycoside analogs
WO2010132760A1 (en) 2009-05-15 2010-11-18 Achaogen, Inc. Antibacterial derivatives of tobramycin
WO2010140832A2 (ko) * 2009-06-04 2010-12-09 안국약품 주식회사 생약 추출물을 함유하는 신장염 질환 예방 또는 치료용 약학 조성물
CN102349655A (zh) * 2011-10-14 2012-02-15 李泼 胶原蛋白多酚冲剂
CN102688305B (zh) * 2012-06-11 2013-12-25 殷中琼 一种防治畜禽大肠杆菌病的中药制剂及其制备方法和应用
EP3037099A4 (en) * 2013-08-21 2017-04-19 Sichuan Jiuzhang Biological Science And Technology Co., Ltd Pharmaceutical composition, preparation method therefor and use thereof
KR20230004886A (ko) * 2013-11-11 2023-01-06 나투렉스 인코포레이티드 하부 요로 증상, 양성 전립선 비대증, 발기부전 치료에 유용한 조성물 및 방법
CN105250280B (zh) 2014-07-14 2020-03-10 诺维科国际控股股份有限公司 包含辛苯聚醇和喹诺里西啶生物碱化合物或其来源的杀微生物组合物
US9662367B2 (en) 2014-08-01 2017-05-30 Rubikon Ltd. Adaptogenic compositions and method for production thereof
EP3242680B1 (en) * 2015-01-08 2021-10-13 Selectimmune Pharma AB Interleukin-1 receptor antagonist for use in the treatment of cystitis
CN105535929A (zh) * 2016-01-25 2016-05-04 张顺涛 一种护理治疗膀胱炎的药物组合物
EP3320897A1 (en) * 2016-11-14 2018-05-16 Dompè Primary S.r.l Process for the preparation of coated cranberry granules with stable proanthocyanidine content
EP3557249A4 (en) * 2016-12-19 2020-09-30 Yukashikado Inc. URINE TESTING DEVICE AND URINE TESTING PROCEDURE
US20180353174A1 (en) * 2017-06-13 2018-12-13 Ethicon Llc Surgical Stapler with Controlled Healing
US10939911B2 (en) 2017-06-13 2021-03-09 Ethicon Llc Surgical stapler with end effector coating
US11058804B2 (en) 2017-06-13 2021-07-13 Ethicon Llc Surgical fastener device for the prevention of ECM degradation
CN108042663B (zh) * 2017-12-28 2021-01-22 宝健（北京）生物技术有限公司 一种美白祛斑且预防泌尿系统感染的组合物及其制备方法和应用
FI128916B (en) * 2018-02-05 2021-03-15 Vetcare Oy Health-promoting composition and method for its preparation
US20210121383A1 (en) * 2018-03-29 2021-04-29 Morinaga Milk Industry Co., Ltd. Composition for anti-aging
CN109106806A (zh) * 2018-06-20 2019-01-01 广州宏韵医药科技股份有限公司 一种女性私密护理洗液及其制备方法
AU2020288361A1 (en) * 2019-06-07 2022-02-03 Selectimmune Pharma Ab Treatment and diagnosis of chronic inflammatory conditions in the lower urinary tract
CN110226593A (zh) * 2019-07-30 2019-09-13 葛亮 一种生物组织冷冻保护液
CN111234322B (zh) * 2020-02-17 2021-11-05 天津大学 一种高抗氧化性可食用包装薄膜及其制备方法
US11266707B2 (en) * 2020-05-04 2022-03-08 Therapeutic Solutions International, Inc. Nutraceuticals for the prevention, inhibition, and treatment of SARS-CoV-2 and associated COVID-19
GB202201139D0 (en) * 2022-01-28 2022-03-16 Selectimmune Pharma Ab Therapeutic agent

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4641151A (en) * 1984-12-28 1987-02-03 Victor Company Of Japan, Limited Thermal transfer recording apparatus
CN1088442A (zh) * 1992-12-25 1994-06-29 李文旭 一种治疗肾炎药物的制取方法
CN1048173C (zh) * 1994-08-11 2000-01-12 王志明 一种治疗性病的中药制剂及其制备方法
EP1486207A3 (en) * 1996-01-23 2011-01-05 Shionogi & Co., Ltd. Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
US6300514B1 (en) * 1997-06-25 2001-10-09 Ono Pharmaceutical Co., Ltd. Aryl (sulfide, sulfoxide and sulfone) derivatives and drugs containing the same as the active ingredient
IL134904A0 (en) * 1997-09-09 2001-05-20 Univ Rutgers Plant proanthocyanidin extract effective at inhibiting adherence of bacteria with p-type fimbriae to surfaces
JP4202493B2 (ja) * 1998-12-04 2008-12-24 財団法人山形県産業技術振興機構 抗菌剤
AU3196200A (en) * 1999-03-26 2000-10-16 Shionogi & Co., Ltd. Beta-amino acid derivatives
EP1167346A4 (en) * 1999-04-06 2003-07-23 Ono Pharmaceutical Co DERIVATIVES OF 4-AMINOBUTANIC ACID AND MEDICINES THAT CONTAIN THESE DERIVATIVES AS ACTIVE ACTIVE SUBSTANCES
US6495578B1 (en) * 1999-04-19 2002-12-17 Shionogi & Co., Ltd. Sulfonamide derivatives having oxadiazole rings
DE60001654D1 (de) * 1999-06-02 2003-04-17 Oxford Natural Products Plc Co Zubereitungen, welche preiselbeeren-frucht, dl-methionin und chinesische kräuter enthalten
JP2001275604A (ja) * 2000-04-04 2001-10-09 Kikkoman Corp 果汁粉末組成物及びその製造方法、並びに該果汁粉末組成物を含有させてなる健康食品
PL366201A1 (en) * 2000-10-26 2005-01-24 Pfizer Products Inc. Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
JP4813652B2 (ja) * 2000-12-04 2011-11-09 丸善製薬株式会社 マトリックスメタロプロテアーゼ阻害剤
US20030108629A1 (en) * 2001-07-17 2003-06-12 Chou Wen Hsien Compositions and methods for prostate and kidney health and disorders, an herbal preparation
KR100456281B1 (ko) * 2001-08-09 2004-11-09 마루젠세이야쿠 가부시키가이샤 방광기능개선제 또는 배뇨장애치료제, 및 방광기능개선용또는 배뇨장애치료용 음식물
JP4219810B2 (ja) * 2001-10-26 2009-02-04 塩野義製薬株式会社 Ｍｍｐ阻害作用を有するスルホンアミド誘導体
PE20030701A1 (es) * 2001-12-20 2003-08-21 Schering Corp Compuestos para el tratamiento de trastornos inflamatorios
GB0204159D0 (en) * 2002-02-22 2002-04-10 British Biotech Pharm Metalloproteinase inhibitors
KR100841901B1 (ko) 2002-03-18 2008-06-27 동화약품공업주식회사 플라보노이드 계열 화합물 또는 이를 포함하는 강진향추출물을 함유한 매트릭스 메탈로프로테이나제 활성저해제 및 기능성 식품
JP2003342179A (ja) 2002-05-24 2003-12-03 Fancl Corp 老化防止剤
JP2004083581A (ja) * 2002-07-02 2004-03-18 Sanki Shoji Kk 尿路感染症の治療剤
WO2004014916A1 (en) * 2002-08-13 2004-02-19 Warner-Lambert Company Llc Pyrimidine fused bicyclic metalloproteinase inhibitors
KR20030011731A (ko) 2002-11-25 2003-02-11 미즈코리아 주식회사 항균 및 미용기능을 갖는 생약추출물과 이를 함유한 제품
US20050031718A1 (en) * 2003-04-10 2005-02-10 Pharmanex, Llc Sea Buckthorn compositions and associated methods
AU2003227952A1 (en) * 2003-05-17 2004-12-03 British Biotech Pharmaceuticals Ltd Metalloproteinase inhibitors
JP2005008539A (ja) 2003-06-17 2005-01-13 Fancl Corp マトリックスメタロプロテイナーゼ阻害剤
WO2005019194A1 (en) * 2003-08-23 2005-03-03 Vernalis (Oxford) Limited Derivatives of hydroxamic acid as metalloproteinase inhibitors
WO2006028523A2 (en) * 2004-04-29 2006-03-16 THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN DIEGO USDC Technology Transfer Office Hydroxypyridinone, hydroxypyridinethione, pyrone, and thiopyrone metalloprotein inhibitors
CN1593530A (zh) * 2004-07-06 2005-03-16 谢子龙 三金分散片及其制备方法
CN100512866C (zh) * 2004-08-13 2009-07-15 贵阳云岩西创药物科技开发有限公司 治疗泌尿系统等疾病的三金药物制剂及其制备方法
CN100360161C (zh) * 2005-09-23 2008-01-09 徐忠慧 一种治疗糖尿病和肾炎的中药
US8153166B2 (en) 2006-06-08 2012-04-10 Chih-Hsiung Lin Composition for prophylaxis or treatment of urinary system infection and method thereof
TWI351965B (en) 2006-06-09 2011-11-11 Chih Hsiung Lin Composition for prophylaxis or treatment of urinar

Also Published As

Publication number Publication date
EP1880719A3 (en) 2008-02-20
US8153166B2 (en) 2012-04-10
US20080124405A1 (en) 2008-05-29
CN101084944A (zh) 2007-12-12
CN101670004A (zh) 2010-03-17
CA2590995C (en) 2015-07-21
CN101670004B (zh) 2012-05-30
CA2590995A1 (en) 2007-12-08
AU2007202584A1 (en) 2008-01-03
JP2007326858A (ja) 2007-12-20
AU2007202584B2 (en) 2013-01-10
HK1142523A1 (en) 2010-12-10
CN101084944B (zh) 2010-08-25
EP1880719A2 (en) 2008-01-23
JP4786598B2 (ja) 2011-10-05
US20090169653A1 (en) 2009-07-02

Similar Documents

Publication Publication Date Title
HK1142523A1 (en) Composition for prophylaxis or treatment of urinary system infection
HK1146084A1 (zh) 用於預防或治療人類呼吸道感染的方法和組合物
HK1134679A1 (zh) 用於治療感染的組合物和方法
AU2007228570A8 (en) Treatment of CNS conditions
EP2043620A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF PARASITIC INFECTIONS
EP2063882A4 (en) TYROSINKINASE INHIBITOR FOR PREVENTING OR TREATING INFECTIONS
ZA201000279B (en) Tissue fragment composition for the treatment of incontinence
EP1996612A4 (en) COMPOSITIONS FOR THE TREATMENT OF CANCER
ZA201105290B (en) Antibiotic compositions for the treatment of gram negative infections
ZA200607889B (en) Dalbavancin compositions for treatment of bacterial infections
GB0718446D0 (en) Compositions and methods for the treatment of infection
ZA200808183B (en) Method of treatment or prophylaxis of inflammatory pain
IL243294A0 (en) Compounds and compositions for the treatment of cancer
IL192745A0 (en) Use of kcnq-openers for treating or reducing the symptoms of schizophrenia
GB0909297D0 (en) Composition for the treatment of skin conditions
LT2111855T (lt) Antibakteriės kompozicijos, skirtos viršutinių ir apatinių kvėpavimo takų infekcijų gydymui
EP2056830A4 (en) SPECIAL COMPOSITIONS FOR TREATMENT OR PREVENTION OF METABOLIC SYNDROME
EP2042188A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF HCV INFECTION
EP2271328A4 (en) ANTISEPTIC COMPOSITIONS FOR THE TREATMENT OF INFECTIONS
HU0500947D0 (en) Composition for treatment of paradontosis
GB0611417D0 (en) Treatment of cndaria intoxication
GB0624439D0 (en) Technique for treatment of gall-and kidney-stones
HUP0500948A2 (en) Composition for treatment of diabeticus paradontosis
AU2006901413A0 (en) Method of treatment or prophylaxis
ZA200805398B (en) Use of kcnq-openers for treating or reducing the symptons of schizophrenia

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190613